Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
In one study, people regained two-thirds of the weight they had lost within a year of stopping treatment
There arent any oral options for either medication at this time
It is worth emphasizing that the gradual approach used did not reduce weight loss or compromise glycemic efficacy, reinforcing that tolerability, not symptom intensity, should guide dose advancement ( A patient centered approach of starting low and going slow prioritizes safety and adherence, building on the principle of doing no harm
10.1080/15548627.2018.1474992 89 PanH.GuanD.LiuX.LiJ.WangL.WuJ.et al (2016)
[5] [6] It is important to note that retatrutide has not yet received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for routine clinical use in the UK
US$ 22.04
US$ 23.75
US$ 21.89
US$ 25.30
